Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Folic Acid No Help With Heart Disease

October 12, 2010 6:05 am | News | Comments

Use of folic acid supplements appears to lower blood levels of the amino acid homocysteine—theorized to be a risk factor for heart and blood vessel disease—but does not appear to be associated with reduced rates of cardiovascular events, cancer or death.

TOPICS:

Racial Disparities Common in Stroke Treatment

October 12, 2010 6:00 am | by Lauran Neergaard | News | Comments

When her stroke hit, Edna Wooten somehow stopped her car. Then her grown daughter ignored her slurred protests and raced her to the hospital - in time for a drug to dissolve the blood clot causing her stroke.

TOPICS:

Geron Testing Stem Cell Treatment in Humans

October 12, 2010 5:54 am | by Damian Troise | News | Comments

Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord injuries, marking the first time such a drug has been used on a human.

TOPICS:
Advertisement

Supreme Court Hearing Vaccine Arguments

October 12, 2010 5:52 am | News | Comments

Parents who say their daughter allegedly suffered serious health problems from a childhood vaccine are trying to persuade the Supreme Court to allow them to sue the manufacturer.

TOPICS:

Pfizer Buying King for $3.6B

October 12, 2010 5:48 am | News | Comments

Pfizer Inc., the world's largest pharmaceutical company by revenue, said it will buy pain drug maker King Pharmaceuticals Inc. for $3.6 billion in cash.

TOPICS:

Digital Microscope

October 11, 2010 11:09 am | Product Releases | Comments

Keyence Corp.’s VHX-1000 digital microscope successfully integrates many of the optical properties and functionalities of stereoscopes, measuring microscopes, and scanning electron microscopes into an all-in-one.

TOPICS:

Optical/SEM Microscope

October 11, 2010 11:03 am | Product Releases | Comments

JEOL USA, Inc. and the Japanese AIST have developed the ClairScope, a tool that couples optical microscopy with an atmospheric scanning electron microscope in an open culture system that retains the samples’ native state while under study.

TOPICS:

Optical Microscope Accessory

October 11, 2010 10:57 am | Product Releases | Comments

VivaTome, an optical microscope accessory from Carl Zeiss and Aurox Ltd., addresses the problem of unwanted blurred information being included with the primary in-focus information from.

TOPICS:
Advertisement

Reading List

October 11, 2010 10:28 am | by Rita C. Peters, Editorial Director | Articles | Comments

This month, I am pleased to share with you some features that are in our magazine, and some that are not. Editors are frequently frustrated by the physical limitations of the printed page.

TOPICS:

Final Rule on Clinical Trial Safety Information

October 11, 2010 10:24 am | News | Comments

In late September, the U.S. Food and Drug Administration issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.

TOPICS:

Reading More from Microplates

October 11, 2010 10:12 am | by Mike May, Contributing Editor | Articles | Comments

Many articles describe assays that work in multi-well plates, but without the technology to read the results these assays are of limited benefit to the drug discovery and development process.

TOPICS:

Disposable Dialysis Plates

October 11, 2010 8:39 am | Product Releases | Comments

Harvard Apparatus offers the 192-Well DispoEquilibrium DIALYZERS that analyze up to 96 samples simultaneously on disposable dialysis plates.

TOPICS:

Personal Microarray System

October 11, 2010 8:37 am | Drug Discovery & Development | Product Releases | Comments

Affymetrix has launched the GeneAtlas System to make Affymetrix microarrays accessible to all life science researchers.

TOPICS:

ImmunoGen Collaborating With Novartis

October 11, 2010 8:29 am | News | Comments

ImmunoGen, Inc. announced that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.

TOPICS:

Exelixis Working With BMS

October 11, 2010 8:24 am | News | Comments

Exelixis, Inc. has entered into two collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading